Open AccessAssessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection
Author(s) -
C.L. Gay,
J.D. Kuruc,
S.D. Falcinelli,
J.A. Warren,
S.A. Reifeis,
J.L. Kirchherr,
K.S. James,
M.G. Dewey,
A. Helms,
B. Allard,
E. Stuelke,
A. Gamble,
A. Plachco,
R.J. Gorelick,
J.J. Eron,
M. Hudgens,
C. Garrido,
N. Goonetilleke,
M.A. DeBenedette,
I.Y. Tcherepanova,
C.A. Nicolette,
N.M. Archin,
D.M. Margolis
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/cqr5-cd21
Subject(s) - vorinostat , human immunodeficiency virus (hiv) , immunotherapy , dendritic cell , immunology , medicine , virology , biology , immune system , histone , histone deacetylase , genetics , gene